Hearts K in the end you have to do-.docVIP

 PAGE \* MERGEFORMAT 15 Hearts K in the end you have to do? Chinese health products market, there is a saying, a health care products from the market to withdraw from the market, often no more than 5 years, that is ‘rich, but contains five’. China has glory in the sun god, the brain of gold, three oral, and so are not out of this circle, forming a ‘giant step down, the dragon folding wings, the sun god sets, three Crushing of bones treating poison’ fate of the industry. Hearts K of Blood-agent market since 94 years, and has the first nine years, and in China’s health care products industry, this should be a miracle. As the blood market, brand, 9 years, Hearts K accumulated nearly 900 million yuan to the state tax. We can say that Hearts K in this area of health care products to obtain sufficient pot of gold, and then K has a smooth transition hearts. Today’s Hearts K Holdings East Lake High-tech listed company, to vigorously develop biological-based bio-pharmaceutical health care, bio-medical materials, bio-cosmetics and bio-pharmaceutical industry; to plant gene-based bio-pesticides, bio-veterinary drugs, biological agriculture and bio-pesticides and other industries. On the surface, it seems that Hearts K thriving, but recently, Hearts K, some moves have to thought-provoking. In early 2002, Heart K Group, a big recruiting, P amp;amp; G’s marketing director, Bristol-Myers Squibb’s marketing director, sales director of Avon’s 500 strong batch of the world’s top talent was recruited to the unit, the industry can not help but sigh, Hearts K in the end you want to do? In fact, this is also the K hearts respond to market changes and challenges of the new strategic needs, Hearts K is looking forward to it is a successful market reform, and has carried out a bold transportation to do. Personnel turnover, remodeling flexible mechanisms Hearts K started from the start, that is, Hsieh Sheng-Ming, Huang Liping, Liu pilgrimage, and a group led by the University of th